Where the research is focused
Research in this area asks how specific peptide signals interact with the body’s natural systems. The aim is to understand mechanisms, identify meaningful outcomes and test questions carefully — not to assume that a promising pathway is already a useful treatment.
What current evidence can tell us
Laboratory and animal studies link MDPs with processes such as mitochondrial function, inflammation and cellular stress responses. Reviews describe these peptides as emerging research targets, while emphasising that the biology and relevance to human ageing are still being worked out.
A peptide’s biological role, a result in a cell or animal model, and a proven benefit in people are different levels of evidence. Human safety and effectiveness require suitable clinical studies and regulatory assessment.
Epithalon · MOTS-c · SS-31
This page introduces published research. It is not medical advice, a treatment recommendation or an invitation to use research compounds. In Australia, the TGA explains that a “research use only” label does not by itself change the regulatory requirements for a therapeutic peptide product. Read the TGA’s overview.